Sangamo Therapeutics (SGMOQ) Liabilities and Shareholders Equity (2010 - 2025)
Sangamo Therapeutics (SGMOQ) posted Liabilities and Shareholders Equity of $59.75 million for Q4 2025, down 41.2% from $101.64 million a year earlier and down 32.6% from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Liabilities and Shareholders Equity (2010 - 2025) Analysis & Trends
Since Q4 2010, Sangamo Therapeutics has reported Liabilities and Shareholders Equity for 60 quarters.
- Annual Liabilities and Shareholders Equity has declined for five consecutive years, with a five-year compound annual growth rate of -42.4% (FY2020 to FY2025).
- In prior years, Sangamo Therapeutics' Liabilities and Shareholders Equity was $101.64 million in FY2024 (-38.5%), $165.32 million in FY2023 (-70.6%), $562.51 million in FY2022 (-22.1%) and $721.92 million in FY2021 (-23.1%).
- The Q4 2025 figure stands as the lowest quarterly Liabilities and Shareholders Equity in data going back to Q4 2010.
- On a year-over-year basis, Liabilities and Shareholders Equity increased in 1 of the last eight quarters, with an average decline of 40.0%.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q1 2021, with growth of 50.1%; the weakest was Q2 2024, with a decline of 71.4%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $88.64 million (Q3 2025), $97.56 million (Q2 2025) and $86.17 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Sangamo Therapeutics | 42.03 Mn | -72.08 Mn | - | 59.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 59.75 Mn |
| Sep 30, 2025 | 88.64 Mn |
| Jun 30, 2025 | 97.56 Mn |
| Mar 31, 2025 | 86.17 Mn |
| Dec 31, 2024 | 101.64 Mn |
| Sep 30, 2024 | 111.26 Mn |
| Jun 30, 2024 | 93.01 Mn |
| Mar 31, 2024 | 128.96 Mn |
| Dec 31, 2023 | 165.32 Mn |
| Sep 30, 2023 | 219.70 Mn |
| Jun 30, 2023 | 325.07 Mn |
| Mar 31, 2023 | 440.57 Mn |
| Dec 31, 2022 | 562.51 Mn |
| Sep 30, 2022 | 593.91 Mn |
| Jun 30, 2022 | 617.13 Mn |
| Mar 31, 2022 | 654.31 Mn |
| Dec 31, 2021 | 721.92 Mn |
| Sep 30, 2021 | 772.40 Mn |
| Jun 30, 2021 | 835.36 Mn |
| Mar 31, 2021 | 877.10 Mn |
API Access
Sangamo Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();